737: CLINICAL FEATURES AND OUTCOMES IN SEVERE PEDIATRIC SCALD BURN PATIENTS

Ashley Daniel(Nationwide Children's Hospital), Jenna Miller(Nationwide Children's Hospital), Lisa Vitale(Nationwide Children's Hospital), Erica Hodgman(Duke University Health System), Pablo Aguayo, Christina Shanti(Wayne State University), Jennifer Flint(Nationwide Children's Hospital), Mariah Malaniak(Nationwide Children's Hospital), Rajan K. Thakkar(Nationwide Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Marita Thompson(Nationwide Children's Hospital), Kelli N Patterson(Nationwide Children's Hospital), Mikaela Miller(Children's Mercy Hospital), Justin D. Klein(Nationwide Children's Hospital)
Critical Care Medicine
December 15, 2022
10.1097/01.ccm.0000908680.48471.63
Cited by 0

Related Papers

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Current concepts in the diagnosis and management of cytokine release syndrome
|Blood|2014|2.8k
CD19 CAR T cell product and disease attributes predict leukemia remission durability
|Journal of Clinical Investigation|2019|355
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
|Nature Medicine|2021|319
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy
|Blood|2019|287